Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gabrielli

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
European Review for Medical and Pharmacological Sciences|February 16, 2016
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infectionF Franceschi, V Ojetti, M Gabrielli, et al.
Minerva Chirurgica|February 28, 1989
[Polyp with invasive carcinoma. Criteria of treatment based on the experience of 31 cases]F Tonelli, S Di Lollo, M Gabrielli, et al.
Alimentary Pharmacology & Therapeutics|December 23, 2003
Atrophic gastritis as a cause of hyperhomocysteinaemiaL Santarelli, M Gabrielli, F Cremonini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2002
Probiotics in antibiotic-associated diarrhoeaF Cremonini, S Di Caro, L Santarelli, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2007
High dosage rifaximin for the treatment of small intestinal bacterial overgrowthE Scarpellini, M Gabrielli, C E Lauritano, et al.
European Review for Medical and Pharmacological Sciences|June 7, 2013
Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndromeE Scarpellini, V Giorgio, M Gabrielli, et al.
Digestive Diseases (Basel, Switzerland)|April 24, 2008
Probiotics: which and when?E Scarpellini, A Cazzato, C Lauritano, et al.
Minerva Gastroenterologica E Dietologica|February 24, 2006
Helicobacter pylori: a culprit in extraintestinal diseases?F Cremonini, F Canducci, M Gabrielli, et al.
Recenti Progressi in Medicina|March 1, 1977
[Influence of physical activity on the behavior of some biohumoral parameters in acute viral hepatitis (A-B). Controlled study]A Morettini, L Bartoletti, G Chibbaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2002
Probiotics and Helicobacter pylori eradicationF Canducci, F Cremonini, A Armuzzi, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
European Review for Medical and Pharmacological Sciences|February 16, 2016
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infectionF Franceschi, V Ojetti, M Gabrielli, et al.
Minerva Chirurgica|February 28, 1989
[Polyp with invasive carcinoma. Criteria of treatment based on the experience of 31 cases]F Tonelli, S Di Lollo, M Gabrielli, et al.
Alimentary Pharmacology & Therapeutics|December 23, 2003
Atrophic gastritis as a cause of hyperhomocysteinaemiaL Santarelli, M Gabrielli, F Cremonini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2002
Probiotics in antibiotic-associated diarrhoeaF Cremonini, S Di Caro, L Santarelli, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2007
High dosage rifaximin for the treatment of small intestinal bacterial overgrowthE Scarpellini, M Gabrielli, C E Lauritano, et al.
European Review for Medical and Pharmacological Sciences|June 7, 2013
Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndromeE Scarpellini, V Giorgio, M Gabrielli, et al.
Digestive Diseases (Basel, Switzerland)|April 24, 2008
Probiotics: which and when?E Scarpellini, A Cazzato, C Lauritano, et al.
Minerva Gastroenterologica E Dietologica|February 24, 2006
Helicobacter pylori: a culprit in extraintestinal diseases?F Cremonini, F Canducci, M Gabrielli, et al.
Recenti Progressi in Medicina|March 1, 1977
[Influence of physical activity on the behavior of some biohumoral parameters in acute viral hepatitis (A-B). Controlled study]A Morettini, L Bartoletti, G Chibbaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 1, 2002
Probiotics and Helicobacter pylori eradicationF Canducci, F Cremonini, A Armuzzi, et al.
Pageof 11